Terminology Service for NFDI4Health
All terms in LOINC
| Label | Id | Description |
|---|---|---|
| Study observation | LP19257-2 | |
| I Ab | Blood product unit | Blood bank | LP398403-8 | |
| I Ab | LP38604-2 | |
| Influenza A (H1) 2009 pandemic detected | LA13027-0 | |
| PhenX measure - personal and family history of hearing loss | LP112560-0 | |
| Multisection:Find:Pt:Upper extremity.left:Doc:CT | 35982-8 | |
| Upper extremity - left | Computed tomography | Radiology | LP405930-1 | |
| Ketobemidone | LP16169-2 | |
| Drugs identified | LP37950-0 | |
| Cefotiam:Susc:Pt:Isolate:OrdQn:Gradient strip | 55645-6 | |
| Cefotiam | Isolate | Antibiotic susceptibilities | LP380565-4 | |
| FLUoxetine | Serum or Plasma | Drug toxicology | LP391051-2 | |
| Mitochondria DNA deletion | LP229001-5 | |
| Sialate:SCnc:Pt:Amnio fld:Qn | 75045-5 | |
| Sialate | Amniotic fluid | Chemistry - non-challenge | LP386153-3 | |
| HLA antigens | LP7806-5 | |
| Foot vessels | LP30418-5 | |
| Lower leg vessels | LP206715-7 | |
| Patient summary.unexpected contact | LP101600-7 | |
| Methanol | XXX | Drug toxicology | LP391447-2 |